| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIC.201402375 |
| P698 | PubMed publication ID | 25572106 |
| P50 | author | Antti Poso | Q40453490 |
| P2093 | author name string | Christian Herrmann | |
| Florenz Sasse | |||
| Thomas Scheper | |||
| Günter Reuter | |||
| Andreas Kirschning | |||
| Johanna-Gabriela Walter | |||
| Carsten Zeilinger | |||
| Wera Collisi | |||
| Klaus Kock | |||
| Emilia Schax | |||
| Simone Eichner | |||
| Jekaterina Hermane | |||
| Ilona Bułyszko | |||
| Pooyan Aliuos | |||
| P2860 | cites work | The biosynthesis of glycopeptide antibiotics?a model for complex, non-ribosomally synthesized, peptidic secondary metabolites | Q35562226 |
| Therapeutic and diagnostic implications of Hsp90 activation | Q35791991 | ||
| Broad substrate specificity of the amide synthase in S. hygroscopicus--new 20-membered macrolactones derived from geldanamycin | Q35797661 | ||
| Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update | Q36066038 | ||
| Mutasynthesis of fluorinated pactamycin analogues and their antimalarial activity | Q36874801 | ||
| Editorial for special issue of JFC on Biomedicinal Chemistry | Q37005539 | ||
| Merging chemical synthesis and biosynthesis: a new chapter in the total synthesis of natural products and natural product libraries | Q37996334 | ||
| Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). | Q38168289 | ||
| New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis | Q39833384 | ||
| Potent non-benzoquinone ansamycin heat shock protein 90 inhibitors from genetic engineering of Streptomyces hygroscopicus | Q39881582 | ||
| The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins | Q40258093 | ||
| Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives | Q40288452 | ||
| Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition | Q40355248 | ||
| Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition. | Q40478778 | ||
| Discovery of novel ansamycins possessing potent inhibitory activity in a cell-based oncostatin M signalling assay. | Q40854306 | ||
| Both the N- and C-terminal chaperone sites of Hsp90 participate in protein refolding | Q43572431 | ||
| Fluorobalhimycin--a new chapter in glycopeptide antibiotic research | Q44151903 | ||
| Cloning and characterization of a gene cluster for geldanamycin production in Streptomyces hygroscopicus NRRL 3602. | Q44314986 | ||
| Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin. | Q45049769 | ||
| Microarray-based screening of heat shock protein inhibitors | Q46097470 | ||
| Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis. | Q46565652 | ||
| Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90. | Q46843707 | ||
| Mutasynthesis of geldanamycin by the disruption of a gene producing starter unit: generation of structural diversity at the benzoquinone ring. | Q52580787 | ||
| Directed biosynthesis of 5"-fluoropactamycin in Streptomyces pactum | Q72513326 | ||
| Reblastatin, a novel benzenoid ansamycin-type cell cycle inhibitor | Q73524379 | ||
| Atomic force microscope | Q21563713 | ||
| The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin | Q24561472 | ||
| Crystal structure and mechanism of a bacterial fluorinating enzyme | Q27643096 | ||
| Fluorine in pharmaceuticals: looking beyond intuition | Q27648640 | ||
| Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors | Q27652213 | ||
| Synthesis of 19-substituted geldanamycins with altered conformations and their binding to heat shock protein Hsp90 | Q27676888 | ||
| Catalysis for fluorination and trifluoromethylation | Q27687352 | ||
| Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent | Q27736012 | ||
| Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone | Q27740876 | ||
| A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays | Q28145712 | ||
| Rational biosynthetic engineering for optimization of geldanamycin analogues | Q28239092 | ||
| Entropic elasticity of lambda-phage DNA | Q28247727 | ||
| Understanding organofluorine chemistry. An introduction to the C-F bond | Q28264762 | ||
| Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety | Q28289076 | ||
| DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90 | Q28376524 | ||
| HSP90 and the chaperoning of cancer | Q29617504 | ||
| Mechanics of proteins with a focus on atomic force microscopy. | Q30359401 | ||
| Force Spectroscopy of Molecular Systems-Single Molecule Spectroscopy of Polymers and Biomolecules | Q30940116 | ||
| Mutational biosynthesis--a tool for the generation of structural diversity in the biosynthesis of antibiotics | Q33211659 | ||
| Total synthesis approaches to natural product derivatives based on the combination of chemical synthesis and metabolic engineering | Q33301352 | ||
| Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. | Q33753331 | ||
| Insights into the biosynthesis of the benzoquinone ansamycins geldanamycin and herbimycin, obtained by gene sequencing and disruption | Q33913477 | ||
| The interplay between mutasynthesis and semisynthesis: generation and evaluation of an ansamitocin library | Q34089152 | ||
| Aminobenzoates as building blocks for natural product assembly lines | Q34230699 | ||
| Chaperone action at the single-molecule level. | Q34368326 | ||
| Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy | Q34915636 | ||
| Overview: Translating Hsp90 Biology into Hsp90 Drugs | Q35551861 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 302-311 | |
| P577 | publication date | 2015-01-08 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | New, non-quinone fluorogeldanamycin derivatives strongly inhibit Hsp90 | |
| P478 | volume | 16 |
Search more.